These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 18359097)
1. Characterization of a trypsin-dependent avian influenza H5N1-pseudotyped HIV vector system for high throughput screening of inhibitory molecules. Ao Z; Patel A; Tran K; He X; Fowke K; Coombs K; Kobasa D; Kobinger G; Yao X Antiviral Res; 2008 Jul; 79(1):12-8. PubMed ID: 18359097 [TBL] [Abstract][Full Text] [Related]
2. Human-like receptor specificity does not affect the neuraminidase-inhibitor susceptibility of H5N1 influenza viruses. Ilyushina NA; Govorkova EA; Gray TE; Bovin NV; Webster RG PLoS Pathog; 2008 Apr; 4(4):e1000043. PubMed ID: 18404209 [TBL] [Abstract][Full Text] [Related]
3. [Establishment of a cell-based 2009 H1N1 influenza neuraminidase inhibitors evaluation system]. Zhang C; Cao YL; Zhong W; Xiao JH; Guo Y Yao Xue Xue Bao; 2010 Mar; 45(3):383-7. PubMed ID: 21351517 [TBL] [Abstract][Full Text] [Related]
4. [Characterization of pseudotyped viruses coated with hemagglutinin of H5N1 avian influenza]. Zhang YS; Wang DY; Gao RB; Dong J; Li Z; Zhang Y; Bai T; Wang M; Wen LY; Shu YL Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Dec; 23(6):401-4. PubMed ID: 20718338 [TBL] [Abstract][Full Text] [Related]
5. HA-pseudotyped retroviral vectors for influenza antagonist screening. Wang SY; Su CY; Lin M; Huang SY; Huang WI; Wang CC; Wu YT; Cheng TJ; Yu HM; Ren CT; Wu CY; Wong CH; Cheng YS J Biomol Screen; 2009 Mar; 14(3):294-302. PubMed ID: 19211776 [TBL] [Abstract][Full Text] [Related]
6. Molecular dynamics simulation of oseltamivir resistance in neuraminidase of avian influenza H5N1 virus. Shu M; Lin Z; Zhang Y; Wu Y; Mei H; Jiang Y J Mol Model; 2011 Mar; 17(3):587-92. PubMed ID: 20517627 [TBL] [Abstract][Full Text] [Related]
7. Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo. Yen HL; Ilyushina NA; Salomon R; Hoffmann E; Webster RG; Govorkova EA J Virol; 2007 Nov; 81(22):12418-26. PubMed ID: 17855542 [TBL] [Abstract][Full Text] [Related]
8. Neuraminidase inhibitors susceptibility profiles of highly pathogenic influenza A (H5N1) viruses isolated from avian species in India (2006-2015). Sood R; Kumar N; Bhatia S; Chanu KV; Gupta CL; Pateriya AK; Mishra A; Khandia R; Mawale N; Singh VP Antiviral Res; 2018 Oct; 158():143-146. PubMed ID: 30125616 [TBL] [Abstract][Full Text] [Related]
9. [Construction of bicistronic eukaryotic expression vector containing HA and M2 genes derived from high pathogenic avian influenza virus (HPAI) H5N1 (Anhui strain)and its efficient expression in mammalian cells]. Liu Y; Zhang K; Tan WJ; Wang HJ; Shu YL; Hu GX; Ruan L Bing Du Xue Bao; 2008 Nov; 24(6):415-20. PubMed ID: 19226948 [TBL] [Abstract][Full Text] [Related]
10. Neuraminidase amino acids 149 and 347 determine the infectivity and oseltamivir sensitivity of pandemic influenza A/H1N1 (2009) and avian influenza A/H5N1. Yongkiettrakul S; Nivitchanyong T; Pannengpetch S; Wanitchang A; Jongkaewwattana A; Srimanote P Virus Res; 2013 Aug; 175(2):128-33. PubMed ID: 23639424 [TBL] [Abstract][Full Text] [Related]
12. [Application and evaluation of a pseudotyped virus assay for screening herbs for anti-H5N1 avian influenza virus]. Liu H; Zhang GL; Shen L; Zeng Z; Zhou BL; Liu CH; Nie G Zhong Xi Yi Jie He Xue Bao; 2010 Nov; 8(11):1036-40. PubMed ID: 21078267 [TBL] [Abstract][Full Text] [Related]
13. Characterization of neuraminidases from the highly pathogenic avian H5N1 and 2009 pandemic H1N1 influenza A viruses. Wu J; Zhang F; Wang M; Xu C; Song J; Zhou J; Lin X; Zhang Y; Wu X; Tan W; Lu J; Zhao H; Gao J; Zhao P; Lu J; Wang Y PLoS One; 2010 Dec; 5(12):e15825. PubMed ID: 21209916 [TBL] [Abstract][Full Text] [Related]
14. A vesicular stomatitis pseudovirus expressing the surface glycoproteins of influenza A virus. Cheresiz SV; Kononova AA; Razumova YV; Dubich TS; Chepurnov AA; Kushch AA; Davey R; Pokrovsky AG Arch Virol; 2014 Oct; 159(10):2651-8. PubMed ID: 24888312 [TBL] [Abstract][Full Text] [Related]
15. Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses. Singh A; Soliman ME Drug Des Devel Ther; 2015; 9():4137-54. PubMed ID: 26257512 [TBL] [Abstract][Full Text] [Related]
16. On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA). Mitrasinovic PM Biophys Chem; 2009 Mar; 140(1-3):35-8. PubMed ID: 19117662 [TBL] [Abstract][Full Text] [Related]
17. Source of oseltamivir resistance in avian influenza H5N1 virus with the H274Y mutation. Malaisree M; Rungrotmongkol T; Nunthaboot N; Aruksakunwong O; Intharathep P; Decha P; Sompornpisut P; Hannongbua S Amino Acids; 2009 Oct; 37(4):725-32. PubMed ID: 19002747 [TBL] [Abstract][Full Text] [Related]
18. [Construction of vectors expressing M2 and NA genes of H5N1 influenza virus]. Guo JQ; Yao LH; Chen AJ; Liu XY; Fu JQ; Xu PW; Zhang ZQ Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Jun; 25(3):167-9. PubMed ID: 21977581 [TBL] [Abstract][Full Text] [Related]
19. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus. Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442 [TBL] [Abstract][Full Text] [Related]
20. [Establishing a high-titer infectious avian influenza A (H5N1) pseudotyped viral particle]. Liu XJ; Guo ZP; Shen LP; Wang Y; Shi HY; Zhang GH; Zhang X; Bi SL; Zhao HL Bing Du Xue Bao; 2012 Jun; 28(4):324-9. PubMed ID: 22978154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]